CHO Pharma, Inc. (TPEX:6586)
Taiwan
· Delayed Price · Currency is TWD 31.05
-0.05 (-0.16%)
At close: Dec 5, 2025
CHO Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -230.38 | -212.23 | -306.09 | -338.39 | -205.93 | -296.84 | Upgrade
|
| Depreciation & Amortization | 26.3 | 25.9 | 28.28 | 39.85 | 39.08 | 41.24 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 52.73 | - | 6 | - | Upgrade
|
| Stock-Based Compensation | -15.43 | -14.3 | -7.66 | 21.99 | -13.84 | -5.02 | Upgrade
|
| Other Operating Activities | -2.88 | -2.96 | -2 | -0.01 | 0 | 0.01 | Upgrade
|
| Change in Accounts Receivable | 0.32 | -0.75 | - | 0.06 | -0.06 | - | Upgrade
|
| Change in Accounts Payable | -12.76 | -2.52 | -52.68 | 38.24 | -16.47 | 14.61 | Upgrade
|
| Change in Other Net Operating Assets | -14.73 | -10.52 | -3.71 | -11.24 | -2.26 | -2.81 | Upgrade
|
| Operating Cash Flow | -244.75 | -217.38 | -291.13 | -249.5 | -193.47 | -248.73 | Upgrade
|
| Capital Expenditures | -3.62 | -5.49 | -2 | -9.4 | -2.64 | -19.16 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -3 | Upgrade
|
| Investment in Securities | 313.9 | 54.8 | -1,860 | - | - | - | Upgrade
|
| Other Investing Activities | -0.21 | 0.09 | 2.57 | 0.39 | -0.39 | 3.12 | Upgrade
|
| Investing Cash Flow | 310.07 | 49.4 | -1,859 | -9.01 | -3.03 | -19.04 | Upgrade
|
| Long-Term Debt Repaid | - | -14.04 | -11.7 | -14.4 | -12.52 | -12.24 | Upgrade
|
| Net Debt Issued (Repaid) | -14.17 | -14.04 | -11.7 | -14.4 | -12.52 | -12.24 | Upgrade
|
| Issuance of Common Stock | - | - | 1,860 | 0.5 | 1.21 | 2.65 | Upgrade
|
| Financing Cash Flow | -14.17 | -14.04 | 1,849 | -13.9 | -11.31 | -9.59 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | 0.04 | 0.05 | 0.09 | -0.6 | -0.71 | Upgrade
|
| Net Cash Flow | 51.1 | -181.98 | -301.87 | -272.33 | -208.41 | -278.07 | Upgrade
|
| Free Cash Flow | -248.37 | -222.87 | -293.13 | -258.9 | -196.11 | -267.89 | Upgrade
|
| Free Cash Flow Margin | -7737.35% | -6225.53% | - | -431501.67% | -5493.25% | -194121.74% | Upgrade
|
| Free Cash Flow Per Share | -1.16 | -1.04 | -1.53 | -1.41 | -1.07 | -1.46 | Upgrade
|
| Cash Interest Paid | 0.54 | 0.68 | 0.08 | 0.3 | 0.58 | 0.78 | Upgrade
|
| Cash Income Tax Paid | 3.07 | 3.11 | 0.46 | 0.01 | - | -0.01 | Upgrade
|
| Levered Free Cash Flow | -178.71 | -165.45 | -206.15 | -140.34 | -128.96 | -168.26 | Upgrade
|
| Unlevered Free Cash Flow | -178.37 | -165.02 | -206.1 | -140.15 | -128.6 | -167.78 | Upgrade
|
| Change in Working Capital | -22.37 | -13.79 | -56.38 | 27.06 | -18.79 | 11.79 | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.